IWPR: Affordable Care Act provision to drive breast-feeding rates up 4%
WASHINGTON — According to a new report released Friday by the Institute for Women’s Policy Research, a provision in the Affordable Care Act of 2010 that requires employers to provide nursing breaks and a private, sanitary place to express breast milk for most mothers employed on an hourly basis will drive breast-feeding rates up by 4% in the first six months. That translates into as many as 165,000 new moms breast-feeding each year, or more than 1 million new moms in six years, noted Robert Drago, director of research with IWPR.
The ACA provisions for breast-feeding cover three-fifths of employed women living in families below 350% of the government poverty line (about $50,000 for a family of two). That’s especially important because it includes a large number of hourly employees — a group that has been historically low in breast-feeding, Drago said.
All told, 19 million women of breast-feeding age will benefit from the new breast-feeding protections, Drago said.
Prestige Brands to acquire Dramamine from McNeil Consumer Healthcare
IRVINGTON, N.Y. — Prestige Brands Holdings on Thursday announced that it has entered into a definitive agreement to acquire the assets associated with the Dramamine business in the United States from McNeil Consumer Healthcare for $76 million in cash.
“The company expects to quickly and smoothly integrate Dramamine into the Prestige portfolio and drive growth through enhanced brand support,” stated Matthew Mannelly, Prestige Brands CEO.
The transaction is expected to close prior to the end of January subject to customary closing conditions.
Dramamine is the market leader in the over-the-counter motion-sickness category in the United States, with an estimated market share of approximately 32%, Prestige reported. Dramamine products are used for the prevention and treatment of nausea, vomiting and dizziness symptoms associated with motion sickness.
Eulactol USA rebrands company as Laderma Health USA
BOCA RATON, Fla. — Eulactol USA, the maker of Flexitol and Natralia brand products, on Friday announced its official corporate name change to Laderma Health USA, effective Jan. 1.
“This new name is better aligned with our long-term strategy, products and categories encompassing skin care and health and well-being products,” stated John Swigert, VP of Laderma Health USA. “We feel this is a very positive step for our company and portrays us more accurately in the marketplace.”
The Sydney, Australia-based principal company, now called Laderma Health International, has expanded globally over the past 20 years, and the international product portfolio has evolved to encompass many different categories across more than 50 countries. As the individual businesses progressed, the company reached the point of needing to rebrand the group of companies and each of the individual operating entities, the company stated.
This change is a corporate rebrand only and does not affect the brands, structure, staff or ownership of the businesses, Laderma Health stated.